No trading implications from this filing; it is a standard, non-material regulatory update. Investors should focus on upcoming clinical data or financing announcements, given the prior going concern risk highlighted in the 20-F.
Price Chart
Executive Summary
Innate Pharma filed a 6-K disclosing its total number of shares outstanding and voting rights as of April 9, 2026, showing 93,860,680 total shares outstanding and updated voting rights figures. This is a routine disclosure required under French regulations and provides no new operational or financial developments.
Key Facts
- Total shares outstanding as of April 9, 2026: 93,860,680
- Breakdown includes 93,847,763 ordinary shares, 5,336 Preferred Shares 2016, and 7,581 Preferred Shares 2017
- Total theoretical voting rights: 94,484,443
- Total exercisable voting rights: 94,465,868
- Disclosure made pursuant to French regulatory requirements (AMF General Regulation)
Financial Impact
No material financial impact
Risk Factors
- Ongoing funding risk remains per the 20-F filing, with a critical financing need beyond Q3 2026
- No indication in this filing that the capital raise or partnership for lacutamab has been secured
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-024822 |
| Document: a6k-iphx2604132.htm | 0001628280-26-024822 |
| Document: 0001628280-26-024822-index-headers.html | 0001628280-26-024822 |
| Document: 0001628280-26-024822-index.html | 0001628280-26-024822 |
| Document: 0001628280-26-024822.txt | 0001628280-26-024822 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 23w ago | 6-K | $2.25 $1.65 | ▼ −26.67% | ▼ −32.96% | $1.51 (−32.93%) |
May 13, 2026 23w ago | 6-K | $1.50 $1.65 | ▼ −10.00% | ▼ −5.56% | $1.51 (−0.60%) |
May 6, 2026 24w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +7.94% | $1.51 (+0.60%) |
Apr 23, 2026 26w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +4.98% | $1.51 (+0.60%) |
Apr 17, 2026 27w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +3.86% | $1.51 (+0.60%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 8, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +9.72% | $1.51 (+9.91%) |
Apr 3, 2026 29w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +6.71% | $1.51 (+9.91%) |
Apr 1, 2026 29w ago | 20-F | $1.37 $1.65 | ▼ −20.17% | ▼ −6.80% | $1.51 (−9.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers